Title Authors Date Link
Assessing the Preparedness of the Australian Health Care System Infrastructure for an Alzheimer's Disease-Modifying Therapy Sangita M. Baxi, Federico Girosi, Jodi L. Liu 2019
Assessing the Preparedness of the Canadian Health Care System Infrastructure for an Alzheimer's Treatment Jodi L. Liu, Jakub P. Hlavka, Daniel T. Coulter, Sangita M. Baxi, Soeren Mattke, Courtney A. Gidengil 2019
Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment Jakub P. Hlavka, Soeren Mattke, Jodi L. Liu 2018
Assessing the Preparedness of the Japanese Health Care System Infrastructure for an Alzheimer’s Treatment Soeren Mattke, Jakub P. Hlávka, Joanne Yoong, Mo Wang, Rei Goto 2019
Assessing the Preparedness of the Korean Healthcare System Infrastructure for an Alzheimer’s Treatment Hankyung Jun, Sang Kyu Cho, Joanne Yoong, Soeren Mattke 2020
Assessing the Preparedness of the Taiwanese Healthcare System Infrastructure for an Alzheimer’s Treatment Hankyung Jun, Sang Kyu Cho, Joanne Yoong, Oliver Yuen, Soeren Mattke 2021
Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment Jenny Lam, Hankyung Jun, Sang Kyu Cho, Mark Hanson, Soeren Mattke 2021
Blood-based biomarkers for Alzheimer's pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times Soeren Mattke, Sang Kyu Cho, Tobias Bittner, Jakub Hlávka, Mark Hanson 2020
The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey Jenny Lam, Jakub Hlávka and Soeren Mattke 2019

Title Authors Date Link
Implications of Alzheimer’s Treatment for Organization and Payment of Medical Practices in the EU-5 Countries Soeren Mattke, Andreas Ullrich and Mo Wang 2020
Implications of Alzheimer’s Treatment for Organization and Payment of Medical Practices in the United States Soeren Mattke and Mo Wang 2020
Implications of Alzheimer’s Treatment for Organization and Payment of Medical Practices in Canada Soeren Mattke and Mo Wang 2021
Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment Jenny Lam, Hankyung Jun, Sang Kyu Cho, Mark Hanson, Soeren Mattke 2021
The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia Marcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, Mark Hanson, Richard Hillestad, Mike Durkin, Antoine C El Khoury, Soeren Mattke 2019
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia Zachary Predmore, Soeren Mattke, Marcela Horvitz-Lennon 2018
Improving Antipsychotic Adherence Among Patients With Schizophrenia: Savings for States Zachary S. Predmore, Soeren Mattke, Marcela Horvitz-Lennon 2015

Title Authors Date Link
Estimating minimal clinically important differences for two scales in patients with chronic traumatic brain injury Soeren Mattke, Steven C. Cramer, Mo Wang, Janet Prvu Bettger, Kevin M.Cockroft, Wuwei Feng, Michael Jaffee, Tolu O. Oyesanya, Ava M. Puccio,Nancy Temkin, Carolee Winstein, Steven L. Wolf, and Michael R. Yochelson 2020
Evidence for Misspecification of a Nationally Used Quality Measure for Substance Use Treatment Soeren Mattke, Zachary Predmore, Elizabeth Sloss, Asa Wilks, Katherine E Watkins 2018
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia Zachary Predmore, Soeren Mattke, Marcela Horvitz-Lennon 2018

Title Authors Date Link
Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment Jenny Lam, Hankyung Jun, Sang Kyu Cho, Mark Hanson, Soeren Mattke 2021
Blood-based biomarkers for Alzheimer's pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times Soeren Mattke, Sang Kyu Cho, Tobias Bittner, Jakub Hlávka, Mark Hanson 2020
How Much Value Would a Treatment for Alzheimer's Disease Offer? Cost-Effectiveness Thresholds for Pricing a Disease-Modifying Therapy Hankyung Jun, Sang K Cho, Elmar R Aliyev, Soeren Mattke, Sze-Chuan Suen 2020
The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia Marcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, Mark Hanson, Richard Hillestad, Mike Durkin, Antoine C El Khoury, Soeren Mattke 2019
Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophrenia Marcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, Mark Hanson, Richard Hillestad, Mike Durkin, Edward Kim, Soeren Mattke 2018
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia Zachary Predmore, Soeren Mattke, Marcela Horvitz-Lennon 2018
Improving Antipsychotic Adherence Among Patients With Schizophrenia: Savings for States Zachary S. Predmore, Soeren Mattke, Marcela Horvitz-Lennon 2015

Title Authors Date Link
Blood-based biomarkers for Alzheimer's pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times Soeren Mattke, Sang Kyu Cho, Tobias Bittner, Jakub Hlávka, Mark Hanson 2020
How Much Value Would a Treatment for Alzheimer's Disease Offer? Cost-Effectiveness Thresholds for Pricing a Disease-Modifying Therapy Hankyung Jun, Sang K Cho, Elmar R Aliyev, Soeren Mattke, Sze-Chuan Suen 2020
Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophrenia Marcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, Mark Hanson, Richard Hillestad, Mike Durkin, Edward Kim, Soeren Mattke 2018
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia Zachary Predmore, Soeren Mattke, Marcela Horvitz-Lennon 2018
The Role of Antipsychotic Plasma Levels in the Treatment of Schizophrenia Marcela Horvitz-Lennon, Soeren Mattke, Zachary Predmore, Oliver D. Howes 2017